Last reviewed · How we verify
NCT06605209: SELECT
Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. (SELECT)
NA trial testing Peripheral Balloon-Expandable Covered Stent System in Peripheral Artery Disease (PAD) in 130 participants. Currently enrolling.
15 July 2026
Quick facts
| Lead sponsor | Zhejiang Zylox Medical Device Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 130 |
| Start date | 8 November 2024 |
| Primary completion | 15 July 2026 |
| Estimated completion | 15 December 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Peripheral Balloon-Expandable Covered Stent System
Conditions studied
- Peripheral Artery Disease (PAD) — all drugs for Peripheral Artery Disease (PAD) →
Sponsor
Zhejiang Zylox Medical Device Co., Ltd.
Who can join
Adults 18 to 80, any sex, with Peripheral Artery Disease (PAD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, multi-center, single-arm clinical trial to evaluate the Peripheral Balloon-Expandable Covered Stent System for treating stenosis and/or occlusion in the common and external iliac arteries. The safety and effectiveness of the stent system will be compared to pre-set performance goals. All treated subjects will have follow-up visits at discharge, and at 1, 6, 12, 24, and 36 months after the procedure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06605209
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peripheral Artery Disease (PAD)
Currently open trials in the same condition.
- NCT07226193 — Detecting Peripheral Artery Disease With the Pulse · NA · recruiting
- NCT07313410 — Using Near-Infrared Light to Better Understand Peripheral Artery Disease · recruiting
- NCT07169045 — Validity and Reliability of the 6-minute Stepper Test in Patients With Peripheral Artery Disease · recruiting
- NCT06687590 — Serranator POINT FORCE Registry · recruiting
- NCT06621264 — Exercise Activity to Improve Mobility in Patients With CKD and PAD · NA · recruiting
Other Zhejiang Zylox Medical Device Co., Ltd. trials
Trials by the same sponsor.
- NCT07049120 — Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions · NA · not yet recruiting
- NCT05841836 — The Safety and Efficacy of the Suture-Mediated Closure System · NA · unknown
- NCT04812444 — Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion · NA · completed
- NCT03844724 — Drug-eluting PTA Balloon Dilatation Catheter in the Treatment of Peripheral Artery Stenosis or Occlusion · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06605209 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zhejiang Zylox Medical Device Co., Ltd.
- Last refreshed: 4 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06605209.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing